GlaxoSmithKline Recalls 3 Lots of Ventolin HFA Inhalers

Looking for:

ventolin 

Click here

The voluntary recall affects three batches of Ventolin HFA 200D inhalers manufactured at a GlaxoSmithKline plant in North Carolina, according to a U.S. The company started pulling the prescription-only product from hospitals, pharmacies and wholesalers March 22. Some inhaler canisters may not contain sufficient propellant to deliver the 200 doses that its label said it can provide through the end of its shelf life. No other lots are affected by the voluntary recall, meaning that, regardless of expiration date or doses indicated in dose counters, only inhalers in these two lots are affected. Drugmaker GSK recalling nearly 600,000 asthma inhalers in U.S. A GSK spokesman spoke with AAFA and said the recall is due to some complaints about the overwrap, or pouches containing the inhalers, becoming inflated by leaking from the product.

GlaxoSmithKline is recalling nearly 600,000 Ventolin asthma inhalers in the United States because of a defect that may cause them to leak. Metered-dose albuterol inhalers are used to deliver medication into the body through the airway and lungs. Albuterol opens airways in the lungs to treat common conditions such as asthma and chronic obstructive pulmonary disease. The defect does not pose an immediate danger to patients, though it could cause the inhaler to deliver a lower dose of the medicine than specified on the package. Users are asked to return any inhalers they have already purchased.

The inhaler may have problems delivering an accurate dose of albuterol sulfate solution, which is a beta-2-Agonist. An asthma attack without an albuterol rescue inhaler can be fatal. Three of the company’s lot numbers of Ventolin HFA 200D inhalers were previously issued nationwide, and are being recalled from all retail stores, hospitals, pharmacies, and wholesalers.

If all else fails, call your doctor if you or your family member don’t feel well. Because asthma definitely isn't something to mess around with. The affected inhalers come from three manufacturing lots at a plant in Zebulon, North Carolina.

According to CBS News, if it’s been leaking, there should be a little bulge in the packaging that you'll notice. It’s not dangerous to patients, which is why customers aren’t being asked to return any inhalers (rather, they're being counseled to throw them out). GlaxoSmithKline is recalling more than 590,000 albuterol inhalers.

On December 3rd, 2015, the US Food and Drug Administration announced a drug recall from GlaxoSmithKline1. The FDA issued the recall due to the product’s canister being defective in their delivery of the medication which may result in a decreased number of available doses. According to Reuters, the affected products have a defect that causes them to deliver a smaller dose of medicine than indicated, which results from a leak in the propellant that delivers the medicine. The U.S. Food and Drug Administration has approved the "Level 2" recall, which means the product may cause temporary or medically reversible side effects. After an elevated number of complaints, drugmaker GSK Plc announced on Tuesday that it is voluntarily recalling nearly 600,000 Ventolin asthma inhalers from hospitals, pharmacies, wholesalers and retailers in the United States.